A detailed history of Claybrook Capital, LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Claybrook Capital, LLC holds 7,950 shares of BDX stock, worth $1.76 Million. This represents 1.19% of its overall portfolio holdings.

Number of Shares
7,950
Previous 8,075 1.55%
Holding current value
$1.76 Million
Previous $2.13 Million 3.57%
% of portfolio
1.19%
Previous 1.15%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 24, 2023

SELL
$254.9 - $283.59 $31,862 - $35,448
-125 Reduced 1.55%
7,950 $2.06 Million
Q2 2023

Jul 17, 2023

SELL
$238.39 - $265.32 $35,758 - $39,798
-150 Reduced 1.82%
8,075 $2.13 Million
Q1 2022

May 06, 2022

SELL
$243.64 - $270.48 $24,364 - $27,048
-100 Reduced 1.2%
8,225 $2.19 Million
Q4 2021

Jan 20, 2022

BUY
$230.08 - $250.94 $34,512 - $37,641
150 Added 1.83%
8,325 $2.09 Million
Q3 2021

Nov 15, 2021

SELL
$232.72 - $256.47 $1.62 Million - $1.78 Million
-6,957 Reduced 45.98%
8,175 $2.01 Million
Q2 2021

Jul 26, 2021

BUY
$232.65 - $254.58 $1.69 Million - $1.85 Million
7,257 Added 92.15%
15,132 $3.59 Million
Q1 2021

Apr 30, 2021

SELL
$232.09 - $256.88 $23,209 - $25,688
-100 Reduced 1.25%
7,875 $1.92 Million
Q4 2020

Feb 02, 2021

BUY
$221.92 - $245.94 $271,852 - $301,276
1,225 Added 18.15%
7,975 $2 Million
Q3 2020

Oct 28, 2020

BUY
$215.77 - $276.76 $269,712 - $345,950
1,250 Added 22.73%
6,750 $1.57 Million
Q2 2020

Jul 29, 2020

BUY
$219.9 - $263.41 $461,790 - $553,161
2,100 Added 61.76%
5,500 $1.32 Million
Q1 2020

May 05, 2020

BUY
$195.69 - $279.01 $665,346 - $948,634
3,400 New
3,400 $781,000
Q1 2019

May 15, 2019

SELL
$206.05 - $248.17 $618 - $744
-3 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$204.73 - $257.93 $614 - $773
3 New
3 $0

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $63.3B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Claybrook Capital, LLC Portfolio

Follow Claybrook Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Claybrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Claybrook Capital, LLC with notifications on news.